FDA Archives

Healthcare Industry News Weekly Wrap-Up: January 20, 2023

// Biotech and Pharma Therapeutics AbbVie, Novartis and more win national coverage in China even as Pfizer’s Paxlovid gets left out January 18, 2023 / China / Drug Reimbursement / Drug Prices / Pfizer Once again, biopharma companies offered hefty...

January 20, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 13, 2023

// Biotech and Pharma Therapeutics J&J puts focus on cancer drugs in push to reach 2025 sales target January 24, 2023 / J&J / Cancer Drugs / Drugmaker Johnson & Johnson is confident it can reach its target of $60...

January 13, 2023

Weekly Wrap-Up

Pharma Industry News Weekly Recap: January 6, 2023

// Biotech and Pharma Therapeutics Lilly, seeking better CNS gene therapies, pays $55M to join AbbVie on AAV specialist’s list of partners January 4, 2023 / Emerging / Biopharma / Eli Lilly / Capsids / Biotherapeutics Eli Lilly has once...

January 6, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 30, 2022

// Biotech and Pharma Therapeutics Drug companies set sights on new Covid medicines to boost depleted arsenal December 28, 2022 / COVID / New Drug / AstrZeneca It was not that long ago that the medical community had a small...

December 30, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 23, 2022

// Biotech and Pharma Therapeutics Pfizer snaps up rights to RSV therapy left behind in ReViral buy for $20M December 19, 2022 / Pfizer / RSV / LianBio / Licensing Deals Pfizer, looking to be the king in respiratory syncytial...

December 23, 2022

Weekly Wrap-Up

Pharma Industry News Weekly Recap: December 16, 2023

// Biotech and Pharma Therapeutics A San Diego startup sees covalent biologics as the next frontier in cancer drugs December 15, 2022 / San Diego / Cancer Drugs / Enlaza Therapeutics / Startup Enlaza’s approach involves introducing what it describes...

December 16, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 9, 2022

December 9, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 2, 2022

// Biotech and Pharma Therapeutics AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program November 28, 2022 / AstraZeneca / Chronic Obstructive Pulmonary Disease / Licensing Deals / Respiratory Diseases AstraZeneca has moved to strengthen its respiratory...

December 2, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 25, 2022

// Biotech and Pharma Therapeutics Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar October 4, 2023 / Boehringer Ingelheim / Humira / AbbVie / Biosimilars After debuting its branded Humira biosim Cyltezo in July, Boehringer has launched...

November 25, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 18, 2022

// Biotech and Pharma Therapeutics Adamis, Harpoon, Neoleukin and Tricida add to biotech layoff wave as pipeline setbacks spur cuts November 15, 2022 / Adamis / Tricida / Layoffs / Restructuring If anyone needed a reminder of the toll the...

November 18, 2022

1 2 … 13 14 15 … 17 18

Tag: FDA

Healthcare Industry News Weekly Wrap-Up: January 20, 2023

Healthcare Industry News Weekly Wrap-Up: January 13, 2023

Pharma Industry News Weekly Recap: January 6, 2023

Healthcare Industry News Weekly Wrap-Up: December 30, 2022

Healthcare Industry News Weekly Wrap-Up: December 23, 2022

Pharma Industry News Weekly Recap: December 16, 2023

Healthcare Industry News Weekly Wrap-Up: December 9, 2022

Healthcare Industry News Weekly Wrap-Up: December 2, 2022

Healthcare Industry News Weekly Wrap-Up: November 25, 2022

Healthcare Industry News Weekly Wrap-Up: November 18, 2022

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: FDA

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺